Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community.

Munson E, Napierala M, Schell RF.

Expert Rev Anti Infect Ther. 2013 Aug;11(8):845-63. doi: 10.1586/14787210.2013.814429. Epub 2013 Aug 14. Review.

PMID:
23944153
2.

Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infection.

Munson E, Kramme T, Napierala M, Munson KL, Miller C, Hryciuk JE.

J Clin Microbiol. 2012 Dec;50(12):3927-31. doi: 10.1128/JCM.02078-12. Epub 2012 Sep 26.

3.

Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.

Seña AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, Atashili J, Cohen MS.

Clin Infect Dis. 2007 Jan 1;44(1):13-22. Epub 2006 Nov 27.

4.

Screening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection.

Munson KL, Napierala M, Munson E, Schell RF, Kramme T, Miller C, Hryciuk JE.

J Clin Microbiol. 2013 Jan;51(1):101-4. doi: 10.1128/JCM.02526-12. Epub 2012 Oct 24.

5.

Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.

Roth AM, Williams JA, Ly R, Curd K, Brooks D, Arno J, Van Der Pol B.

Sex Transm Dis. 2011 May;38(5):398-400. doi: 10.1097/OLQ.0b013e318203e3ce.

PMID:
21217417
6.

Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.

Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR.

Clin Infect Dis. 2014 Sep 15;59(6):834-41. doi: 10.1093/cid/ciu446. Epub 2014 Jun 13.

7.

Trichomoniasis: the "neglected" sexually transmitted disease.

Meites E.

Infect Dis Clin North Am. 2013 Dec;27(4):755-64. doi: 10.1016/j.idc.2013.06.003. Epub 2013 Oct 25. Review.

8.

Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.

Meites E, Llata E, Braxton J, Schwebke JR, Bernstein KT, Pathela P, Asbel LE, Kerani RP, Mettenbrink CJ, Weinstock HS.

Sex Transm Dis. 2013 Nov;40(11):865-9. doi: 10.1097/OLQ.0000000000000038.

9.

The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L.

Clin Infect Dis. 2007 Nov 15;45(10):1319-26. Epub 2007 Oct 15.

11.

A comparative evaluation of the Papanicolaou test for the diagnosis of trichomoniasis.

Lobo TT, Feijó G, Carvalho SE, Costa PL, Chagas C, Xavier J, Simoes-Barbosa A.

Sex Transm Dis. 2003 Sep;30(9):694-9.

PMID:
12972792
12.

Real-time PCRs for detection of Trichomonas vaginalis beta-tubulin and 18S rRNA genes in female genital specimens.

Simpson P, Higgins G, Qiao M, Waddell R, Kok T.

J Med Microbiol. 2007 Jun;56(Pt 6):772-7.

PMID:
17510262
13.

Trichomoniasis in teens: an update.

Huppert JS.

Curr Opin Obstet Gynecol. 2009 Oct;21(5):371-8. doi: 10.1097/GCO.0b013e32832e0827. Review.

PMID:
19491679
14.

Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.

Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, van de Wijgert J, Mmiro F, Mugerwa R, Chipato T, Morrison CS.

J Infect Dis. 2008 Feb 15;197(4):548-54. doi: 10.1086/526496.

15.

Role of polymerase chain reaction in the diagnosis of Trichomonas vaginalis infection in human immunodeficiency virus-infected individuals from India (South).

Paul H, Peter D, Pulimood SA, Abraham OC, Mathai E, Prasad JH, Kannangai R.

Indian J Dermatol Venereol Leprol. 2012 May-Jun;78(3):323-7. doi: 10.4103/0378-6323.95448.

16.

Improved detection by DNA amplification of Trichomonas vaginalis in males.

Schwebke JR, Lawing LF.

J Clin Microbiol. 2002 Oct;40(10):3681-3.

17.

APTIMA® Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens.

Chapin K, Andrea S.

Expert Rev Mol Diagn. 2011 Sep;11(7):679-88. doi: 10.1586/erm.11.53. Review.

PMID:
21902528
18.

Trichomonas vaginalis as a cause of urethritis in Malawian men.

Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Zimba D, Daly CC, Chakraborty H, Cohen MS, Hoffman I.

Sex Transm Dis. 1999 Aug;26(7):381-7.

PMID:
10458630
19.

Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs.

Miller M, Liao Y, Gomez AM, Gaydos CA, D'Mellow D.

J Infect Dis. 2008 Feb 15;197(4):503-9. doi: 10.1086/526497.

20.

[Trichomoniasis].

Yasuda J.

Nihon Rinsho. 2009 Jan;67(1):162-6. Review. Japanese.

PMID:
19177767
Items per page

Supplemental Content

Write to the Help Desk